Louisiana State Employees Retirement System’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.58M Sell
50,400
-800
-2% -$23.6K 0.02% 789
2026
Q1
$1.27M Sell
51,200
-1,700
-3% -$40.5K 0.02% 859
2025
Q4
$1.23M Hold
52,900
0.02% 887
2025
Q3
$1.04M Sell
52,900
-700
-1% -$14.4K 0.02% 984
2025
Q2
$1.16M Buy
53,600
+800
+2% +$18.9K 0.02% 874
2025
Q1
$1.28M Sell
52,800
-1,400
-3% -$31.5K 0.03% 795
2024
Q4
$1.13M Buy
54,200
+300
+0.6% +$6.45K 0.02% 913
2024
Q3
$1.07M Sell
53,900
-2,600
-5% -$48.2K 0.02% 977
2024
Q2
$875K Buy
56,500
+1,200
+2% +$18.7K 0.02% 1058
2024
Q1
$881K Buy
55,300
+5,200
+10% +$78.4K 0.02% 1074
2023
Q4
$842K Sell
50,100
-900
-2% -$12.3K 0.02% 1088
2023
Q3
$596K Sell
51,000
-200
-0.4% -$2.67K 0.01% 1217
2023
Q2
$688K Buy
51,200
+6,600
+15% +$95K 0.02% 1158
2023
Q1
$739K Sell
44,600
-900
-2% -$14.8K 0.02% 1024
2022
Q4
$846K Buy
45,500
+300
+0.7% +$4.62K 0.02% 898
2022
Q3
$580K Buy
+45,200
New +$536K 0.02% 1101

Other funds holding CPRX

Louisiana State Employees Retirement System's CPRX Position: Q2 2026 in Review

Louisiana State Employees Retirement System reduced its Catalyst Pharmaceutical (CPRX) stake by 1.6% in Q2 2026, selling an estimated $23.6K and leaving 50,400 shares worth $1.58M. The position accounts for 0.02% of the portfolio, ranked #789.

Louisiana State Employees Retirement System first reported a position in CPRX in Q3 2022 and has held it in 16 quarters since. 83 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Louisiana State Employees Retirement System held 50,400 shares of Catalyst Pharmaceutical worth $1.58M as of Q2 2026.
  • Louisiana State Employees Retirement System sold 800 Catalyst Pharmaceutical shares in Q2 2026, an estimated $23.6K.
  • Catalyst Pharmaceutical made up 0.02% of Louisiana State Employees Retirement System's portfolio in Q2 2026, its #789 holding.
  • Louisiana State Employees Retirement System first reported a position in Catalyst Pharmaceutical in Q3 2022 and has held it in 16 quarters since.
  • 83 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Louisiana State Employees Retirement System's 13F filing for Q2 2026, filed 20 Jul 2026.